๐Financials๐PE Ratio๐ฅงShareholding๐ฐDividend๐Quarterlyโ๏ธBalance Sheet๐นP&L๐Cash Flow
SANOFIPharmaceuticals
Sanofi India Limited โ PE Ratio & Valuation Analysis
โน3209.70
-3.82%
Current P/E27.17xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E26.5x2.7% above avg
โ
14.5% Discount to Industry
SANOFI P/E 27.17x vs sector avg 31.77x
๐
Historical PE Ratio
| Year | EPS (โน) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | โน179.46 | โน6123 | 34.1x |
| 2023 | โน261.78 | โน8068 | 30.8x |
| 2022 | โน269.47 | โน5853 | 21.7x |
| 2021 | โน410.06 | โน7887 | 19.2x |
PE = Year-end closing price รท Diluted EPS. Source: NSE/BSE filings.
๐ก
Understanding Sanofi India Limited Valuation
Sanofi India Limited (SANOFI) currently trades at 27.17x earnings. The Pharmaceuticals sector average PE is 31.77x. SANOFI is trading at a discount to peers โ may indicate relative value. Historically, SANOFI has traded at an average PE of 26.5x โ it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only โ not investment advice.
ROE
47.15%
Dividend Yield
2.68%
More on Sanofi India Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.